These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23166053)

  • 1. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.
    Moore N; Gulmez SE; Larrey D; Pageaux GP; Lignot S; Lassalle R; Jové J; Pariente A; Blin P; Bénichou J; Bégaud B
    Pharmacoepidemiol Drug Saf; 2013 Feb; 22(2):160-7. PubMed ID: 23166053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study.
    Gulmez SE; Larrey D; Pageaux GP; Lignot S; Lassalle R; Jové J; Gatta A; McCormick PA; Metselaar HJ; Monteiro E; Thorburn D; Bernal W; Zouboulis-Vafiadis I; de Vries C; Perez-Gutthann S; Sturkenboom M; Bénichou J; Montastruc JL; Horsmans Y; Salvo F; Hamoud F; Micon S; Droz-Perroteau C; Blin P; Moore N
    Drug Saf; 2013 Feb; 36(2):135-44. PubMed ID: 23325533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study.
    Gulmez SE; Unal US; Lassalle R; Chartier A; Grolleau A; Moore N
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1174-1181. PubMed ID: 30112779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant associated with paracetamol overdose: results from the seven-country SALT study.
    Gulmez SE; Larrey D; Pageaux GP; Bernuau J; Bissoli F; Horsmans Y; Thorburn D; McCormick PA; Stricker B; Toussi M; Lignot-Maleyran S; Micon S; Hamoud F; Lassalle R; Jové J; Blin P; Moore N
    Br J Clin Pharmacol; 2015 Sep; 80(3):599-606. PubMed ID: 26017643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT).
    Gulmez SE; Larrey D; Pageaux GP; Lignot-Maleyran S; de Vries C; Sturkenboom M; Perez-Gutthann S; Bénichou J; Bissoli F; Horsmans Y; Bernuau J; Stricker B; Thorburn D; Blin P; Moore N
    Eur J Clin Pharmacol; 2013 Mar; 69(3):605-16. PubMed ID: 22878690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics.
    Moore N; Scheiman JM
    Postgrad Med; 2018 Mar; 130(2):188-199. PubMed ID: 29417856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics.
    Sturkenboom M; Nicolosi A; Cantarutti L; Mannino S; Picelli G; Scamarcia A; Giaquinto C;
    Pediatrics; 2005 Jul; 116(1):e26-33. PubMed ID: 15930187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).
    Vlahovic-Palcevski V; Wettermark B; Bergman U
    Eur J Clin Pharmacol; 2002 Jun; 58(3):209-14. PubMed ID: 12107607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation: Results from the Study of Acute Liver Transplant (SALT).
    Gulmez SE; Moore N; Pageaux GP; Lignot S; Horsmans Y; Stricker B; Bernuau J; Bissoli F; Thorburn D; Montastruc JL; Micon S; Hamoud F; Lassalle R; Jové J; Blin P; Larrey D
    Drug Saf; 2013 Sep; 36(9):757-64. PubMed ID: 23743692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.
    Lacroix I; Lapeyre-Mestre M; Bagheri H; Pathak A; Montastruc JL; ;
    Fundam Clin Pharmacol; 2004 Apr; 18(2):201-6. PubMed ID: 15066135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-efficiency of nonsteroidal anti-inflammatory drug prescribing in Zagreb, Croatia.
    Vukusić I; Stimac D; Culig J
    Coll Antropol; 2005 Jun; 29(1):143-7. PubMed ID: 16117313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee.
    McManus P; Primrose JG; Henry DA; Birkett DJ; Lindner J; Day RO
    Med J Aust; 1996 May; 164(10):589-92. PubMed ID: 8637461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.
    Schmidt M; Christiansen CF; Mehnert F; Rothman KJ; Sørensen HT
    BMJ; 2011 Jul; 343():d3450. PubMed ID: 21727167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between prescribing nonsteroidal anti-inflammatory drugs and the potential prescription-related problems in a primary care setting.
    Dhabali AA; Awang R; Hamdan Z; Zyoud SH
    Int J Clin Pharmacol Ther; 2012 Dec; 50(12):851-61. PubMed ID: 23006441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver injury from nonsteroidal anti-inflammatory drugs in the United States.
    Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW;
    Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy.
    Donati M; Conforti A; Lenti MC; Capuano A; Bortolami O; Motola D; Moretti U; Vannacci A; Rafaniello C; Vaccheri A; Arzenton E; Bonaiuti R; Sportiello L; Leone R;
    Br J Clin Pharmacol; 2016 Jul; 82(1):238-48. PubMed ID: 26991794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
    Arellano FM; Yood MU; Wentworth CE; Oliveria SA; Rivero E; Verma A; Rothman KJ
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study.
    Figueiras A; Estany-Gestal A; Aguirre C; Ruiz B; Vidal X; Carvajal A; Salado I; Salgado-Barreira A; Rodella L; Moretti U; Ibáñez L;
    Pharmacogenet Genomics; 2016 Feb; 26(2):66-73. PubMed ID: 26544900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample.
    Duong M; Abouelfath A; Lassalle R; Droz C; Blin P; Moore N
    Drug Saf; 2018 Nov; 41(11):1049-1058. PubMed ID: 29797240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver damage and nonsteroidal anti-inflammatory drugs: case non-case study in the French Pharmacovigilance Database].
    Bareille MP; Montastruc JL; Lapeyre-Mestre M
    Therapie; 2001; 56(1):51-5. PubMed ID: 11322018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.